Ignite Creation Date:
2025-12-24 @ 12:30 PM
Ignite Modification Date:
2026-04-15 @ 6:53 PM
Study NCT ID:
NCT02408861
Status:
TERMINATED
Last Update Posted:
2025-09-23
First Post:
2015-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-03
First Submit QC Date:
None
Study First Post Date:
2015-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2025-07-16
Results First Submit QC Date:
None
Results First Post Date:
2025-09-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-04
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED